Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Sage Therapeutics, Inc.
| Metric | Sage Therapeutics, Inc. SAGEHealthcare |
|---|---|
| Quality Score | 35 / 100 |
| Revenue (latest) | $41M |
| Net income (latest) | −$401M |
| Operating margin | −1048.3% |
| Net margin | −971.5% |
| Return on equity | −86.1% |
| Return on assets | −73.2% |
| Return on capital (ROCE) | −90.9% |
| Debt / equity | 0.18× |
| Revenue growth (YoY) | −52.3% |
| Altman Z″ (distress) | -11.55 |
| Accruals / assets | −24.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.